$1.97
2.07% yesterday
Nasdaq, Nov 25, 09:44 pm CET
ISIN
US26745T1016
Symbol
DYAI
Sector
Industry

Dyadic International, Inc. Stock price

$1.91
+0.85 80.19% 1M
-0.04 2.05% 6M
+0.30 18.63% YTD
+0.10 5.52% 1Y
-1.97 50.77% 3Y
-4.31 69.29% 5Y
+0.59 44.70% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.02 1.04%
ISIN
US26745T1016
Symbol
DYAI
Sector
Industry

Key metrics

Market capitalization $56.52m
Enterprise Value $51.97m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 15.47
P/S ratio (TTM) P/S ratio 16.82
P/B ratio (TTM) P/B ratio 16.56
Revenue growth (TTM) Revenue growth 13.82%
Revenue (TTM) Revenue $3.36m
EBIT (operating result TTM) EBIT $-6.53m
Free Cash Flow (TTM) Free Cash Flow $-4.20m
Cash position $9.92m
EPS (TTM) EPS $-0.22
P/E forward negative
P/S forward 13.14
EV/Sales forward 12.09
Short interest 0.89%
Show more

Is Dyadic International, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Dyadic International, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Dyadic International, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Dyadic International, Inc.:

Buy
100%

Financial data from Dyadic International, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
3.36 3.36
14% 14%
100%
- Direct Costs 1.19 1.19
49% 49%
35%
2.17 2.17
244% 244%
65%
- Selling and Administrative Expenses 6.35 6.35
9% 9%
189%
- Research and Development Expense 2.35 2.35
22% 22%
70%
-6.53 -6.53
21% 21%
-194%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -6.53 -6.53
21% 21%
-194%
Net Profit -6.33 -6.33
8% 8%
-188%

In millions USD.

Don't miss a Thing! We will send you all news about Dyadic International, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Dyadic International, Inc. Stock News

Neutral
GlobeNewsWire
5 days ago
Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable Therapeutics Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable Therapeutics
Neutral
Seeking Alpha
9 days ago
Dyadic International, Inc. (NASDAQ:DYAI ) Q3 2024 Earnings Conference Call November 12, 2024 5:00 PM ET Company Participants Ping Rawson - CFO Mark Emalfarb - President & CEO Joseph Hazelton - COO Patrick Lucy - Chairman Conference Call Participants John Vandermosten - Zacks Robert Hoffman - Princeton Opportunity Management Operator Operator Good evening, and welcome to Dyadic International Q3 ...
Neutral
GlobeNewsWire
22 days ago
JUPITER, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as in non-pharmaceutical applications including food, nutrition, and wellness, today announced that it will r...
More Dyadic International, Inc. News

Company Profile

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.

Head office United States
CEO Mark Emalfarb
Employees 7
Founded 1979
Website www.dyadic.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today